Abstract
Background: Application of magnetic nanoparticles as a drug delivery system has attracted great attention in the cancer therapy, interests in the pH and thermo-sensitive polymers have been increased exponentially in biomedicine.
Objective: (N-isopropylacrylamide)-ethylene glycol dimethacrylate copolymer was coated on the surface of Fe3O4 magnetic nanoparticles and utilized as a pH and temperature responsive nanocarrier for encapsulation and delivery of doxorubicin, as an anti-cancer drug. Method: First, Fe3O4 nanoparticles were prepared through the chemical co-precipitation method and then coated by poly (N-isopropylacrylamide)-ethylene glycol dimethacrylate copolymer shell. The synthesized nanocarrier were later used as a drug carrier for the DOX drug delivery. Results: Nanocarriers were characterized by a number of techniques i.e. scanning electron microscopy (SEM), dynamic light scattering (DLS(X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FT-IR), Thermo gravimetric analysis (TGA) and vibrating sample magnetometer (VSM). The effects of pH and temperature on the drug release rate were evaluated. The obtained result revealed that doxorubicin release rate of the polymer is temperature and pH dependent, which are desirable properties for a selective delivery system. At the end of 72 h, only 15% of doxorubicin had been released in pH 7.4 conditions comparing to that of 58% in pH 5.8 acidic conditions at 40°C. Conclusion: This project improves the delivery of anti-cancer drug. The preparation of this nanocarrier was simple and fast and the prepared sorbent is biocompatible.Keywords: Controlled release, doxorubicin, poly (N-isopropylacrylamide) magnetic nanocomposite, selective drug delivery, TGA, XRD.
Graphical Abstract
Pharmaceutical Nanotechnology
Title:Synthesis of Cross-linked Poly (N-isopropylacrylamide) Magnetic Nano Composite for Application in the Controlled Release of Doxorubicin
Volume: 5 Issue: 1
Author(s): Sharif Kaamyabi*, Abed Badrian and Abolfazl Akbarzadeh
Affiliation:
- Department of Chemistry, Farhangian University, P.O. Box 15875-4874, Tehran,Iran
Keywords: Controlled release, doxorubicin, poly (N-isopropylacrylamide) magnetic nanocomposite, selective drug delivery, TGA, XRD.
Abstract: Background: Application of magnetic nanoparticles as a drug delivery system has attracted great attention in the cancer therapy, interests in the pH and thermo-sensitive polymers have been increased exponentially in biomedicine.
Objective: (N-isopropylacrylamide)-ethylene glycol dimethacrylate copolymer was coated on the surface of Fe3O4 magnetic nanoparticles and utilized as a pH and temperature responsive nanocarrier for encapsulation and delivery of doxorubicin, as an anti-cancer drug. Method: First, Fe3O4 nanoparticles were prepared through the chemical co-precipitation method and then coated by poly (N-isopropylacrylamide)-ethylene glycol dimethacrylate copolymer shell. The synthesized nanocarrier were later used as a drug carrier for the DOX drug delivery. Results: Nanocarriers were characterized by a number of techniques i.e. scanning electron microscopy (SEM), dynamic light scattering (DLS(X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FT-IR), Thermo gravimetric analysis (TGA) and vibrating sample magnetometer (VSM). The effects of pH and temperature on the drug release rate were evaluated. The obtained result revealed that doxorubicin release rate of the polymer is temperature and pH dependent, which are desirable properties for a selective delivery system. At the end of 72 h, only 15% of doxorubicin had been released in pH 7.4 conditions comparing to that of 58% in pH 5.8 acidic conditions at 40°C. Conclusion: This project improves the delivery of anti-cancer drug. The preparation of this nanocarrier was simple and fast and the prepared sorbent is biocompatible.Export Options
About this article
Cite this article as:
Kaamyabi Sharif*, Badrian Abed and Akbarzadeh Abolfazl, Synthesis of Cross-linked Poly (N-isopropylacrylamide) Magnetic Nano Composite for Application in the Controlled Release of Doxorubicin, Pharmaceutical Nanotechnology 2017; 5 (1) . https://dx.doi.org/10.2174/2211738505666170109155247
DOI https://dx.doi.org/10.2174/2211738505666170109155247 |
Print ISSN 2211-7385 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-7393 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
A beta oligomerization A Therapeutic Target for Alzheimers Disease
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents The Role of Autophagy in the Pathogenesis of Ischemic Stroke
Current Neuropharmacology Sirtuins: Common Targets in Aging and in Neurodegeneration
Current Drug Targets Immunological Mechanisms of Neuropsychiatric Lupus
Current Immunology Reviews (Discontinued) Effects of Vitamin A Deficiency and Opioids on Parvalbumin + Interneurons in the Hippocampus of the HIV-1 Transgenic Rat
Current HIV Research A New Investigational Perspective for Purines Against Glioblastoma Invasiveness
Current Drug Targets Cerebral Arachidonate Cascade in Dementia: Alzheimers Disease and Vascular Dementia
Current Neuropharmacology MIIP, a Cytoskeleton Regulator that Blocks Cell Migration and Invasion, Delays Mitosis, and Suppresses Tumorogenesis
Current Protein & Peptide Science Dangerous Liaisons between Beta-Amyloid and Cholinergic Neurotransmission
Current Pharmaceutical Design Role of GSK-3 in Cardiac Health: Focusing on Cardiac Remodeling and Heart Failure
Current Drug Targets Role of Mu and Delta Opioid Receptors in Alcohol Drinking Behaviour
Current Drug Abuse Reviews Biochemical Properties of Indoleamine 2,3-dioxygenase: From Structure to Optimized Design of Inhibitors
Current Medicinal Chemistry Target Therapies in Pancreatic Carcinoma
Current Medicinal Chemistry Strain Specificity and Drug Resistance in Anti-Prion Therapy
Current Topics in Medicinal Chemistry Current View from Alzheimer Disease to Type 2 Diabetes Mellitus
CNS & Neurological Disorders - Drug Targets Current Evaluation of the Millennium Phytomedicine- Ginseng (II): Collected Chemical Entities, Modern Pharmacology, and Clinical Applications Emanated from Traditional Chinese Medicine
Current Medicinal Chemistry Recent Development in the Discovery of Anaplastic Lymphoma Kinase (ALK) Inhibitors for Non-small Cell Lung Cancer
Current Medicinal Chemistry Pharmacological and Biological Activities of Benzazepines: An Overview
Current Bioactive Compounds Phycobilins and Phycobiliproteins Used in Food Industry and Medicine
Mini-Reviews in Medicinal Chemistry Strategies Targeting Soluble β-Amyloid Oligomers and their Application to Early Diagnosis of Alzheimer’s Disease
Current Alzheimer Research